Please login to the form below

Not currently logged in
Email:
Password:

PPRS negotiations nearing end, says Bridgehead

An international biopharmaceutical consultancy group claimed, on June 10, that negotiations about the Pharmaceutical Price Regulation Scheme could be concluded as early as next week

An international biopharmaceutical consultancy group claimed, on June 10, that negotiations about the Pharmaceutical Price Regulation Scheme (PPRS) could be concluded as early as next week.

Bridgehead International says that it believes that the government and the Association of the British Pharmaceutical Industry (ABPI) are close to agreeing a new voluntary PPRS and that an announcement could come as early as the 3rd week of June 2008.

ABPI spokesperson, Roz Britton, explained that a voluntary PPRS would be agreed upon by the industry and the government, as appose to having the conditions of the scheme imposed on the sector.

"As far as we know, the negotiations are still ongoing," said Roz Britton, spokesperson for the ABPI.

"We have an agreement with the Department of Health, that as long as negotiations are ongoing, that we have agreed not to comment."

Director of market access at Bridgehead, Jim Furniss, did say that the 'word on the street' is that the negotiations are close to conclusion but would not confirm where this information had come from or who the company's sources were. He did explain that it was 'unrealistic' to expect details of the negotiation to remain confidential.

12th June 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hive

We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...

Latest intelligence

Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

Infographics